• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MICROVENTION, INC. AZUR CX 35 DETACHABLE; DEVICE, VASCULAR, FOR PROMOTING EMBOLIZATION

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MICROVENTION, INC. AZUR CX 35 DETACHABLE; DEVICE, VASCULAR, FOR PROMOTING EMBOLIZATION Back to Search Results
Model Number 45-751632
Medical Device Problem Code Premature Separation (4045)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 01/30/2023
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
A search for non-conformances associated with the reported part/lot number combination did not reveal any production-related issues relevant to the complaint that occurred during manufacturing of the device.The device was returned to the manufacturer; however, its evaluation is not complete.A supplemental report will be submitted when the investigation is completed.The instructions for use (ifu) identifies premature coil detachment as potential complications associated with use of the device.
 
Event or Problem Description
It was reported that the case was for embolization of a left hypogastric artery using left femoral access.When the 4th coil was advanced it unintentionally detached in the microcatheter.Physician attempted to flush and push out the coil but was unsuccessful.The coil was removed along with the microcatheter and replaced with another coil to successfully complete the case.The patient was fine.
 
Event or Problem Description
See h10.
 
Additional Manufacturer Narrative
Additional information: h3, h6, h10 (summary device evaluation).Summary device evaluation: the investigation of the returned coil system found the implant to be severely stretched at the proximal section with the gel exposed, damaged, deformed and separated from the pusher.The pusher's heater coil showed no signs of activation using a detachment controller.The investigation found the pusher's monofilament with a tensile break shape at the tip, which is consistent with the device experiencing excessive force that exceeded the strength of the monofilament causing the implant to separate from the pusher.The physical evaluation of the device could not identify the conditions or circumstances that led to the damage, but the damage is consistent with the device experiencing forces over specification.The microcatheter used in the procedure was not evaluated as a part of this evaluation, so the investigation could not determine if it had caused or contributed to the reported complaint.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
AZUR CX 35 DETACHABLE
Common Device Name
DEVICE, VASCULAR, FOR PROMOTING EMBOLIZATION
Manufacturer (Section D)
MICROVENTION, INC.
35 enterprise
aliso viejo CA 92656
Manufacturer Contact
terrence callahan
35 enterprise
aliso viejo, CA 92656
7142478000
MDR Report Key16376005
Report Number2032493-2023-00570
Device Sequence Number6142602
Product Code KRD
UDI-Device Identifier00812636021096
UDI-Public(01)00812636021096(11)211125(17)261031(10)0000129474
Combination Product (Y/N)N
Initial Reporter StateWI
Initial Reporter CountryUS
PMA/510(K) Number
K151358
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source Health Professional,User Facility,Company Representative
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 01/30/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Model Number45-751632
Device Catalogue Number45-751632
Device Lot Number0000129474
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer02/14/2023
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 01/30/2023
Supplement Date Received by Manufacturer02/24/2023
Initial Report FDA Received Date02/14/2023
Supplement Report FDA Received Date03/02/2023
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured11/25/2021
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Patient Age79 YR
Patient SexMale
Patient Weight73 KG
-
-